Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-05-27
2008-05-27
Sullivan, Daniel M. (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S023500, C536S024310
Reexamination Certificate
active
07378239
ABSTRACT:
The differentiation between ulcerative colitis and Crohn's disease is made possible by a multi-gene approach where gene expression profiles in biopsy samples obtained from inflamed, and optionally also non-inflamed, areas in the intestines of a patient are studied.
REFERENCES:
patent: 2003/0158254 (2003-08-01), Zerangue et al.
Lawrence et al. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidte genes. Human Molecular Genetics, vol. 10, No. 5, pp. 445-456, 2001.
Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, MD. MIM No.: 607178: Nov. 22, 2002: , World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
Anderle et al. Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes. BMC Genomics, vol. 6, No. 1, p. 69 (pp. 1/17-17-17), May 2005.
GenBank Accession No. XM—010112.1, GI: 11419739, publicly available Nov. 2000.
Haila et al. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types. The Journal of Histochemistry & Cytochemistry, vol. 49, No. 8, pp. 973-982, Aug. 2001.
Hastbacka et al. Identification of the Finnish founder mutation for diastrophic dysplasia (DTD). European Journal of Human Genetics, vol. 7, No. 6, pp. 664-670, Sep. 1999.
Buck et al. Design strategies and performance of custom DNA sequencing primers. Biotechniques, vol. 27, No. 3, pp. 528-536, Sep. 1999.
A. Imada et al., “Coordinate Upregulation of Interleukin-8 and Growth-Related Gene Product-60 is Present in the Colonic Mucosa of Inflammatory Bowel Disease,” Scand. J. Gastroenterol., V. 36, 2001, pp. 854-864.
Ken J. Newell et al., “Matrilysin (Matrix Metalloproteinase-7) Expression in Ulcerative Colitis-Related Tumorigenesis,” Molecular Carcinogenesis, V. 34, 2002, pp. 59-63.
Kim L. Isaacs et al., “Cytokine Messenger RNA Profiles in Inflammatory Bowel Disease Mucosa Detected by Polymerase Chain Reaction Amplification,” Gastroenterology, V. 103, 1992, pp. 1587-1595.
J.C. Hartupee et al., “Isolation and Characterization of a cDNA Encoding a Novel Member of the Human Regenerating Protein Family: Reg IV1,” Biochimica et Biophysica Acta, V. 1518, 2001, pp. 287-293.
Keiki Matsuno et al., “The Expression of Matrix Metalloproteinase Matrilysin Indicates the Degree of Inflammation in Ulcerative Colitis,” Journal of Gastroenterology, V. 38, 2003, pp. 348-354.
Dieckmann Andreas
Lofberg Robert
Von Stein Oliver
Von Stein Petra
DLA Piper (US) LLP
Dunston Jennifer
InDex Diagnostics AB
Sullivan Daniel M.
LandOfFree
Method of differentiating between ulcerative colitis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of differentiating between ulcerative colitis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of differentiating between ulcerative colitis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2762295